Stock Events

Roche 

$34.04
1211
-$0.07-0.21% Friday 20:00

Statistics

Day High
34.12
Day Low
33.87
52W High
39.92
52W Low
29.2
Volume
125,348
Avg. Volume
3,100,067
Mkt Cap
194.86B
P/E Ratio
14.5
Dividend Yield
3.96%
Dividend
1.35

Upcoming

25
JUL
Earnings
14
MAR 25
Dividend Ex
3
MAY 25
Dividend Payment
14
MAR 26
Dividend Ex
3
MAY 26
Dividend Payment

Dividends

3.96%Dividend Yield
May 24
$1.35
Mar 23
$1.28
Mar 22
$1.24
Mar 21
$1.22
Mar 20
$1.14
10Y Growth
1.98%
5Y Growth
4.66%
3Y Growth
3.4%
1Y Growth
5.47%

Earnings

25JulConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Next
0
3.96
7.91
11.87
Expected EPS
10.244579
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RHHBY. It's not an investment recommendation.
Alphabet
67930
GOOGL
Apple
60132
AAPL
Microsoft
55863
MSFT
Amazon
51453
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap233.14B
Novartis competes directly with Roche in multiple areas including oncology, neuroscience, and immunology, making it a primary competitor.
Pfizer
PFE
Mkt Cap158.55B
Pfizer competes with Roche in the pharmaceutical sector, particularly in the development of cancer and immunology drugs.
Merck &
MRK
Mkt Cap313.56B
Merck is a key competitor in the oncology space, directly competing with Roche's cancer drug portfolio.
Johnson & Johnson
JNJ
Mkt Cap351.76B
Johnson & Johnson competes across a broad range of healthcare products, including pharmaceuticals that overlap with Roche's offerings.
Abbvie
ABBV
Mkt Cap302.88B
AbbVie competes in the biopharmaceutical field, particularly in areas like immunology and oncology, overlapping with Roche's interests.
AMGEN
AMGN
Mkt Cap167.61B
Amgen competes with Roche in the biotech sector, especially in cancer and hematology.
Bristol-Myers Squibb
BMY
Mkt Cap84.19B
Bristol Myers Squibb competes in the pharmaceutical and biopharmaceutical sectors, particularly in cancer, which is a key area for Roche.
GSK
GSK
Mkt Cap79.79B
GlaxoSmithKline competes with Roche in several areas including pharmaceuticals and vaccines.
Sanofi
SNY
Mkt Cap122.89B
Sanofi competes with Roche in the pharmaceutical sector, including treatments for rare diseases, which Roche also focuses on.
Astrazeneca
AZN
Mkt Cap241.81B
AstraZeneca competes with Roche in the development of drugs for various diseases, including cancer, respiratory, and cardiovascular diseases.

About

Pharmaceuticals: Major
Health Technology
Manufacturing
Medicinal and Botanical Manufacturing
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Show more...
CEO
Severin Schwan
Employees
103605
Country
US
ISIN
US7711951043
WKN
000891106

Listings

SW
CH
RO.SW
OTCM
US
RHHBF
LSE
GB
0TDF.LSE
LSE
GB
0QQ6.LSE